On average, our board members have 20 years of industry experience.
They leverage their shared business, operational and clinical knowledge to help our members develop thriving solutions for today’s dynamic healthcare sector.
They leverage their shared business, operational and clinical knowledge to help our members develop thriving solutions for today’s dynamic healthcare sector.
Alex Albert is a Founding Partner of Patient Square Capital. He has over 15 years of investment and acquisition experience. Prior to joining Patient Square, Albert was a Partner at Ares Management where he served as the co-head of healthcare within the Private Equity Group. Most recently, Albert served on the Board of Directors of the parent entities of DuPage Medical Group, National Veterinary Associates, Ob Hospitalist Group and Unified Women’s Healthcare.
Albert holds a B.A., magna cum laude, from Vanderbilt University in Economics and an M.A. from Columbia University in Quantitative Methods. He also holds an M.Phil from Oxford University in Economics. Mr. Albert is a CFA® charterholder.
Ms Christensen is a Partner and Co-Head of Healthcare at The Vistria Group. Prior to joining Vistria, Ms. Christensen was a Vice President at NewSpring Capital, a middle market private equity firm with a family of funds, including a dedicated healthcare fund. Prior to NewSpring, Ms. Christensen was an investment professional with the Gores Group and Calder Capital Partners. Ms. Christensen began her career as a healthcare consultant with the Huron Consulting Group.
Ms. Christensen currently serves on the Board of Directors of Behavioral Health Group, Chiro One, Supplemental Healthcare, Beacon Specialized Living, and Sandstone Care. She previously served on the boards of St. Croix Hospice, Angel Medflight, and Alacura.
Ms. Christensen received a B.S. from Northwestern University summa cum laude and an M.B.A. from The University of Chicago Booth School of Business where she was an Andrew Alper Merit Scholar.
Mark is a member of TA’s Management, Core Investment and Portfolio Committees. He joined TA in 2005 and has more than 22 years of experience in the private equity and investment banking industries. While at TA, Mark has been responsible for leading numerous healthcare investments totaling more than $10 billion in enterprise value. He has deep expertise in the healthcare segment and has partnered with founders and management to accelerate growth through acquisitions, new product development and organic initiatives.
Prior to joining Apax, Andrew spent eleven years at Vestar Capital Partners where he was a Managing Director and Co-Head of the Healthcare Sector. At Vestar, Andrew was involved with a number of investments including Press Ganey, Essent Healthcare, StayWell, Joerns Healthcare, Sunrise Medical, Institutional Shareholder Services (ISS) and Veritas Collaborative. Andrew came to Vestar in 2006 from The Blackstone Group. Prior to Blackstone, Andrew was a Senior Associate at JPMorgan Partners. Andrew started his career as an Analyst in Leveraged Finance at Merrill Lynch.
Andrew holds an MBA from Columbia Business School and a BA, cum laude, in Economics and Government from Cornell University.
Mr. Crosby received a BA from Boston College and an MBA from the Harvard Business School. Mr. Crosby is a board member of Blue Cross Blue Shield of RI where he is on the Compensation and Finance Committees.
Ms. Daly has a BS in Economics from The Wharton School of the University of Pennsylvania and an MBA from Harvard Business School. She currently serves on the boards of Advance Dermatology and Dental Care Alliance.
Mr. Husain received an Sc.B. degree in Chemical Engineering from Brown University, and an M.B.A. from Harvard Business School. He is on the Board of Advisors for The School of Engineering at Brown University. He lives in New York City, with his wife and three children.
Prior to Frazier, Ben was at Morgan Stanley Capital Partners (MSCP), focusing on investing in the healthcare sector. Before joining MSCP, he was in the Healthcare Investment Banking Group of Morgan Stanley.
Ben is also an Advisor for American Corporate Partners, a nationwide mentoring program dedicated to helping veterans transition to the private sector.
Ben received his M.B.A from the Tuck School of Business at Dartmouth and his B.B.A. in Finance and Computer Applications from the University of Notre Dame.
John Maldonado joined Advent in 2006 focusing on buyouts in the healthcare, financial and business services sectors. His previous private equity experience includes positions at both Bain Capital and Parthenon Capital. During his career, John has worked on 24 investments, 19 during his time at Advent, including AccentCare, Bharat Serums and Vaccines, Cotiviti, Definitive Healthcare, Genoa Healthcare, RA Chem Pharma Limited and RxBenefits.
John began his career as a Consultant with The Parthenon Group, a leading strategy consulting firm. He earned a BA, summa cum laude, from Dartmouth College and an MBA, with high distinction, as a Baker Scholar from Harvard Business School.
Mr. O’Leary received a B.A. from Washington and Lee University.
Mr. Sachdev joined CD&R in 2015. He played a key role in the Firm’s investments in agilon health, naviHealth, TRANZACT, and Covetrus. Previously, he served as a managing director and co-head of healthcare services at J.P. Morgan, advising senior healthcare company executives on strategic initiatives, M&A, and capital markets. In that role, Mr. Sachdev advised on multiple transactions including the sale of Medco to Express Scripts, Vanguard to Tenet, Trizetto to Cognizant, and the IPOs of HealthEquity, SCA, Premier, and IMS Health. He serves on the board of the Healthcare Private Equity Association. Mr. Sachdev has a B.A. in economics from the University of Michigan.
Directorships
CD&R Investments
Before joining DW Healthcare Partners, Doug worked for Bain & Company. While there, Doug led strategic due diligence efforts as part of Bain’s Private Equity Group. Prior to joining Bain’s Private Equity Group, Doug advised Bain’s commercial clients in the consumer products and food service industries.
Doug received a Bachelors degree from Cornell University and an MBA with Distinction from Harvard Business School, and previously sat on the Harvard Business School Alumni Board of Directors.
He has been focused on healthcare private equity since 1998 when he was a founding member of the healthcare team at First Chicago Equity Capital (currently JP Morgan). Mr. Miller began his career in the investment banking division of Salomon Brothers, Inc. (currently Citigroup). He has served on a number of boards: BarrierSafe Solutions International, CORPAK Medsystems, HYCOR BioMedical, SeraCare, Life Sciences Strata Pathology, and Suture Express.
Mr. Miller holds a Bachelor of Arts with honors in Economics from Princeton University and an MBA from Harvard Business School with a concentration in healthcare. He is a Board Member of AdvaMedDx, the founder of Private Equity Analysts of Chicago, a Trustee of the Latin School of Chicago, and a member of the Economic Club of Chicago.
Michael earned an MBA from Harvard Business School, an MA from Oxford University where he was a Thouron Scholar and undergraduate degrees from the Wharton School and the College of Arts and Sciences at the University of Pennsylvania. He is a member of the Council on Foreign Relations.
Diane earned an MBA from the Tuck School at Dartmouth College and a BA in Economics from Lehigh University.
Prior to leading healthcare private equity, Terry led global venture capital and growth equity at OTPP. OTPP has a global portfolio in healthcare private equity, leading deals in North America, Europe and Asia. Terry and the healthcare team led/co-led investments including: Inc Research, Amica Senior Lifestyles, Heartland Dental, Asia Pacific Healthcare Group, Phynet Dermatology, PetVet Care Centers, Acorn Health, Nvision Eye Centers, and Abano Healthcare. Terry has a Ph.D. from McGill University and an MBA from Michigan State.
Craig’s board directorships and investments include HealthCare Partners (merged with DaVita, NYSE: DVA), Integrated DNA Technologies (acquired by Danaher), Healthline Media (acquired by Red Ventures), National Veterinary Associates (acquired by Ares Management), BluePearl Veterinary Services (acquired by Mars Petcare), Independent Vetcare (acquired by EQT), MedSpring Urgent Care (acquired by Fresenius Medical Care), Physicians Formula (NASDAQ: FACE) and Solutionreach.
Prior to Summit, Craig was founder and manager of three successful companies. He was also the Chief Medical Resident at the University of California, San Francisco. Craig holds a BA in psychology, with honors, from Cornell University and an MD from Cornell University Medical College, where he was valedictorian and received the Paul Sherlock Prize, a peer-voted award for exceptional integrity and compassion in patient care. He is the creator of the Saint-Frances Series, medical books that are used extensively in academic centers across the United States.
Craig has numerous publications in leading journals, including the New England Journal of Medicine, and has collaborated with many national healthcare leaders. He serves as an advisor to the Cornell University Trustees Investment Committee regarding private equity, and he is a former President of the Healthcare Private Equity Association (HCPEA). Craig has been named one of the 40 Smartest People in Healthcare by Becker’s Hospital Review.